Sign in

Kevin Salim

@kevinsalim.bsky.social
1.7K followers 1.2K following 4 posts

Graduate Student | Levings Lab | BC Children’s Hospital Research Institute | Regulatory T Cells | He/him 🏳️‍🌈

PostsRepliesMedia
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 13/08/2026
Preclinical evaluation of nitrated α-synuclein-specific CAR-Treg therapy in Parkinson’s disease @cp-cellrepmed.bsky.social www.cell.com/cell-reports...
081
Reposted by Kevin Salim
Sarah Crome @sarahcrome.bsky.social · 12/08/2026
Thanks @labwaggoner.bsky.social! All datasets publicly available on GEO. While we focus on #ILC2, #ILC3s and #NKcells, we capture all immune cells in human spleen. So hoping the datasets can be a good resources for the community!
032
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 11/08/2026
Congrats, @sarahcolpitts.bsky.social & @sarahcrome.bsky.social! Spatial and functional specialization of human splenic innate lymphoid cells (#ILC #NK) www.nature.com/articles/s41...
183
Reposted by Kevin Salim
Francis Lynn 🇨🇦 @nictitate.bsky.social · 13/06/2026
Excited to see this out! www.science.org/doi/10.1126/sciadv.…
science.org
Regenerative macrophages enhance stem cell–derived β cell function and engraftment
SC-β and SC-MReg coaggregates have improved insulin secretion, metabolic function, and reverse hyperglycemia in diabetic mice.
1124
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 27/05/2026
Review @moltherapy.bsky.social @mklevings.bsky.social Engineering human T cells with antigen receptors for immune regulation in autoimmune disease and transplantation www.cell.com/molecular-th...
cell.com
Engineering human T cells with antigen receptors for immune regulation in autoimmune disease and transplantation
Engineered T cell therapies have transformed cancer treatment and similar principles are being applied in autoimmunity and transplantation. In this review Levings and colleagues discuss strategies to ...
021
Reposted by Kevin Salim
Cell Reports Methods @cp-cellrepmethods.bsky.social · 19/05/2026
Reproducible detection of antigen-specific T cells and Tregs via standardized and automated activation-induced marker assay workflows
dlvr.it
Reproducible detection of antigen-specific T cells and Tregs via standardized and automated activation-induced marker assay workflows
Halvorson et al. characterize the variability associated with AIM assays and present strategies to minimize technical variability. Box-Cox-based correction for background signals, optimized AIM protocols for CD4+ and CD8+ T cells and Tregs, and automated gating software reduce unwanted variability and enhance signal detection, streamlining AIM assays for clinical adoption.
011
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 11/03/2026
Treatment with an IL-2–TGFβ ‘surrogate’ co-agonist quelled immune activation in mouse models of allergen-induced allergic inflammation and self-antigen-driven autoimmune neuroinflammation @stanforduniversity.bsky.social @nature.com www.nature.com/articles/s41...
072
Reposted by Kevin Salim
DMM Journal @dmmjournal.bsky.social · 02/03/2026
Luo Ting Huang, Yaser Tahamtani, @nictitate.bsky.social & co explored the possibility of magnetic selection of insulin-expressing stem cell‑derived β‑cells using a CRISPR/Cas9 technology and transmembrane glycoprotein CD19 as a marker. @bcchresearch.bsky.social Read: doi.org/10.1242/dmm....
The figure shows gene expression analysis of unsorted, CD49 sorted and CD19 sorted SCβ-cells using NanoString analysis.
034
Reposted by Kevin Salim
BCCHR ResDev (DM) @resdevbcch.bsky.social · 27/02/2026
This is an OUTSTANDING LIFE-CHANGING outcome, based on research and healthcare by @turveylab.bsky.social and colleagues @bcchresearch.bsky.social Hooray for the family! Hooray for Stuart T & the other clinicians and scientists! ❤️🎉❤️🎉❤️🎉❤️
082
Reposted by Kevin Salim
Canadian Affairs @cdnaffairs.bsky.social · 18/02/2026
Researchers in B.C. have unlocked a way to grow vital immune cells from stem cells. This breakthrough could lead to mass produced cancer therapies that are faster and cheaper than current custom treatments.
153
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 16/02/2026
Review @natbiotech.nature.com Clinical progress of engineered cellular immunotherapies for autoimmunity www.nature.com/articles/s41...
031
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 12/02/2026
Review @annualreviews.bsky.social Tissue Regulatory T Cells www.annualreviews.org/content/jour... @labliston.bsky.social
0144
Reposted by Kevin Salim
Nick Adams @nickadams-phd.bsky.social · 12/02/2026
Very happy to share the final chapter of my postdoc work with Boris Reizis @NYU @uchicagocoi.bsky.social published today in @science.org! We identify and define the role of transcription factor ETV3 in the tolerogenic function of dendritic cells (DCs). 1/ www.science.org/doi/10.1126/...
science.org
Transcription factor Etv3 controls the tolerogenic function of dendritic cells
Dendritic cells (DCs) facilitate the maintenance of immunological tolerance in the steady state. We report that transcription factor Etv3 is preferentially expressed in mature DCs, including tissue-de...
2154
Reposted by Kevin Salim
Joe Sabatino @jsabatino37.bsky.social · 05/02/2026
Overjoyed to share our new work exploring the antigen specificity of CSF-expanded CD8+ T cells in #multiplesclerosis #EBV in @natimmunol.nature.com #immunology 🧪🧵1/ www.nature.com/articles/s41...
nature.com
Antigen specificity of clonally enriched CD8+ T cells in multiple sclerosis - Nature Immunology
Sabatino and colleagues examine expanded CD8+ T cell clonotypes from a small cohort of multiple sclerosis patients. They identified several cognate peptide epitopes that derive from Epstein–Barr virus...
85922
Reposted by Kevin Salim
Arthur Mortha @theonlylabever.bsky.social · 22/01/2026
Please share and distribute ILC6 6th International Conference on Innate Lymphoid Cells in Vancouver, BC Canada Abstract submission and registration are open: ilc6vancouver.com #immunosky #ILC6vancouver #ILC6 Lots of presenter spots available!!! Get those hot abstracts out.
042
Reposted by Kevin Salim
Sarah Crome @sarahcrome.bsky.social · 22/01/2026
The new Crome Lab at BC Cancer is up and running — and we’re hiring! We’re recruiting a PDF for a newly funded project on ILCs & NK cells in Type 1 Diabetes, using spatial genomics and single-cell approaches. 🔗 jobs.phsa.ca/job/postdoct... #Immunology #SingleCell #SpatialGenomics #Type1Diabetes
jobs.phsa.ca
Postdoctoral Fellow - Innate Lymphoid Cells and Spatial Genomics in Type 1 Diabetes, Crome Lab, Terry Fox Laboratory - BC Cancer Vancouver | Working at Provincial Health Services Authority | Careers a...
Postdoctoral Fellow - Innate Lymphoid Cells and Spatial Genomics in Type 1 Diabetes, Crome Lab, Terry Fox Laboratory BC Cancer Vancouver, BC We are recruiting a highly motivated Postdoctoral Fellow to...
0910
Reposted by Kevin Salim
Bruce Verchere @bruceverchere.bsky.social · 14/01/2026
New publication @diabetologiajnl.bsky.social led by a fantastic former fellow on our team @hdenroche.bsky.social. Islet amyloid, long viewed as pathogenic for beta cells, surprisingly disrupts antigen presentation and delays autoimmune diabetes in NOD mice.
1135
Reposted by Kevin Salim
Paul Layug @pauljerardl.bsky.social · 14/01/2026
Check out our protocol for streamlined isolation and immunophenotyping of leukocytes from various mouse tissues! Excited to implement these in our in vivo mouse models to better understand the immune system and harness it for safe and effective immunotherapies. @um-radyfhs.bsky.social
064
Reposted by Kevin Salim
Science in Vancouver @scienceinvancouver.com · 13/01/2026
For the first time, researchers at UBC have demonstrated how to reliably produce #TCells from stem cells in a lab setting. See the work from Dr. @jonesr18.bsky.social, @kevinsalim.bsky.social, and the Zandstra & Levings labs: bit.ly/4qJcXhi Abstract: bit.ly/45QKIFo
0103
Kevin Salim @kevinsalim.bsky.social · 08/01/2026
Excited to share this work done in collaboration between @mklevings.bsky.social lab and @jonesr18.bsky.social from Peter Zandstra’s lab, on making human CD4 T cells from pluripotent stem cells!
174
Reposted by Kevin Salim
Ross D. Jones, PhD @jonesr18.bsky.social · 08/01/2026
Finally out - fully-defined, feeder-free production of CD4+ helper T cells from induced pluripotent stem cells (iPSCs)! Turns out you need to turn Notch down.... a notch 🥁 And you need to fine-tune stimulation of the T cell receptor ⚖️ www.cell.com/cell-stem-ce...
cell.com
Tunable differentiation of human CD4+ and CD8+ T cells from pluripotent stem cells
Jones et al. demonstrate that Notch signaling suppresses CD4+ (helper) T cell induction from PSCs and that manipulating TCR and Notch signaling enables control over CD4+ vs. CD8+ (cytotoxic) T cell pr...
272
Reposted by Kevin Salim
UBC News @news.ubc.ca · 08/01/2026
Big breakthrough for living drugs. UBC researchers have discovered how to grow “helper” immune cells from stem cells—paving the way for more effective and accessible off-the-shelf immune therapies. Learn more: news.ubc.ca/2026/01/stem...
A researcher works at a laboratory bench using instruments and samples during experiments related to developing stem cell‑based immune therapies.
0117
Reposted by Kevin Salim
FOCIS - Federation of Clinical Immunology Societies @focisimmunology.bsky.social · 07/01/2026
🚨 Introducing: The next FOCIS Journal Club 🎓 CAR Treg cells mediate linked suppression and infectious tolerance in islet transplantation in mice 🗓️ Wed, Jan 28, 2026 🕚 10 AM–11 AM CT 🎤 Christine Wardell, PhD Student & Megan Levings, PhD 🔗: zurl.co/gsIJC
011
Reposted by Kevin Salim
Omer Dushek @tcell.bsky.social · 05/01/2026
🚀 Our new Publication in Nature Biomedical Engineering!🎉 📄 Title: Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors 🔗 Read the full paper here: www.nature.com/articles/s41...
nature.com
Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors - Nature Biomedical Engineering
This study shows that T cell cross-reactivity is influenced by the co-signalling molecules CD5, CD8 and CD4, and that cytotoxic T cells with a CD8→CD4 co-receptor switch show reduced cross-reactivity ...
1163
Reposted by Kevin Salim
Diabetologia @diabetologiajnl.bsky.social · 31/12/2025
While islet amyloid harms β cells in T2D, research reveals amyloid protects against β cell autoimmunity and diabetes in NOD mice by disrupting MHCII antigen presentation in islet macrophages link.springer.com/article/10.1... 🔓
link.springer.com
Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice - Diabetologia
Aims/hypothesis Islet amyloid contributes to beta cell failure in type 2 diabetes through several mechanisms, one being the potent induction of local islet inflammation through activating inflammatory...
072
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 16/12/2025
@biorxivpreprint.bsky.social Clinical development of gene edited tacrolimus-resistant Treg (FKBP12KO-Treg) to enable simultaneous immunosuppression and support of immune regulation www.biorxiv.org/content/10.6...
041
Reposted by Kevin Salim
bioRxiv Immunology @biorxiv-immuno.bsky.social · 13/12/2025
Clinical development of gene edited tacrolimus-resistant Treg (FKBP12KO-Treg) to enable simultaneous immunosuppression and support of immune regulation www.biorxiv.org/content/10.64898/20…
052
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 10/12/2025
Erythropoietin receptor on cDC1s dictates immune tolerance @nature.com @stanforduniversity.bsky.social www.nature.com/articles/s41...
0124
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 11/12/2025
Type 1 diabetes is associated with impaired T cell effector differentiation and regulatory T cell dysfunction, both of which may contribute to immune imbalance and loss of self-tolerance @natcomms.nature.com @adaptiveimmunity.bsky.social @czechacademy.bsky.social www.nature.com/articles/s41...
0103
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 07/11/2025
Engineered β cells with a mutant CD155 help evade immune attack, offering a promising therapeutic approach for type 1 diabetes @bruskolab.bsky.social www.science.org/doi/10.1126/...
science.org
Human stem cell-derived β cells expressing an optimized CD155 reduce cytotoxic immune cell function for application in type 1 diabetes
Engineered β cells with a mutant CD155 help evade immune attack, offering a promising therapeutic approach for type 1 diabetes.
042
Reposted by Kevin Salim
Francis Lynn 🇨🇦 @nictitate.bsky.social · 05/11/2025
Although things could always be better, it's great to see the government continuing to support research in this environment...a rising tide lifts all boats.
041
Reposted by Kevin Salim
FOCIS - Federation of Clinical Immunology Societies @focisimmunology.bsky.social · 05/11/2025
The FOCIS 2026 Scientific Program Committee has curated an exciting & dynamic program, featuring 4 keynote speakers and cutting-edge sessions in immunology. 🔬 Learn More: 🔗 zurl.co/P98Ja #FOCIS2026 #immunology #science
011
Reposted by Kevin Salim
Science in Vancouver @scienceinvancouver.com · 28/10/2025
New data from Christine Wardell and the Levings lab at UBC and @bcchresearch.bsky.social has demonstrated that A2-CAR Treg cells have potential therapeutic use to simultaneously control both allo- and #autoimmunity in islet transplantation. Check it the paper: bit.ly/4nq3SIg
065
Reposted by Kevin Salim
Stem Cell Network @stemcellnetwork.ca · 29/10/2025
SCN is offering trainee travel awards to attend MASSIV 1.0: The Meeting for Advanced Synthetic Biology and Systems Bioengineering. Don’t miss this chance to connect with leading experts in #SyntheticBiology, #bioengineering, and #RegenerativeMedicine. 🤝 🔗 stemcellnetwork.ca/training/wor...
MASSIV 1.0:
031
Reposted by Kevin Salim
Stem Cell Network @stemcellnetwork.ca · 27/10/2025
(1/3) 📢 SCN is pleased to announce the release of our 'What We Heard' report, Preparing Canada’s Health System for Regenerative Medicines and Advanced Therapeutics: Cell Therapies for Type 1 Diabetes. 🔗 Read the report: stemcellnetwork.ca/wp-content/u...
Preparing Canada’s Health System for Regenerative Medicines and Advanced Therapeutics: Cell Therapies for Type 1 Diabetes
111
Reposted by Kevin Salim
Chrysothemis Brown @chrysothemisbrown.bsky.social · 17/10/2025
Excited to share our review on Thetis cells and dendritic cells, and their roles in mucosal immunity and tolerance @natimmunol.nature.com rdcu.be/eLtB1
urldefense.com
Antigen-presenting cells as arbiters of mucosal tolerance and immunity
Nature Immunology - Brown and colleagues review the heterogeneity of mucosal antigen-presenting cells that orchestrate T cell immunity to intestinal antigens.
0196
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 13/10/2025
HLA matching or CRISPR editing HLA-I/II enables engraftment & function of allo human Treg therapy in a humanized mouse transplantation model @natcomms.nature.com @dlwagner.bsky.social @bcmhouston.bsky.social www.nature.com/articles/s41...
0123
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 08/10/2025
Temporal and context-dependent requirements for the transcription factor Foxp3 expression in regulatory T cells @natimmunol.nature.com @yuripritykin.bsky.social Rudensky @princetonupress.bsky.social @mskcancercenter.bsky.social www.nature.com/articles/s41...
0258
Reposted by Kevin Salim
Nephrology Journal Club @nephjc.bsky.social · 29/09/2025
Chimerism might just be the 🔑 to immune tolerance and ending the need for immunosuppression 🚫💊after transplantation 🫘. Join the discussion 9/30/25 at 9 pm EST on Bluesky #NephSky #MedSky #NephJC www.nephjc.com/news/chimera-tolerance-njqe334
nephjc.com
Chimerism and Immune Tolerance: Can We Says Goodbye to Immunosuppression? — NephJC
This week, we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients.
01712
Reposted by Kevin Salim
Adrian Liston @labliston.bsky.social · 19/09/2025
For our #flowcytometry peeps, would you like to have a single fix/perm protocol that is optimised for everything? One that preserves fluorophores while allowing simultaneous TF and cytokine staining? How about 100-fold cheaper? You got it: currentprotocols.onlinelibrary.wiley.com/doi/10.1002/...
currentprotocols.onlinelibrary.wiley.com
1015869
Reposted by Kevin Salim
John Ray @jraylab.bsky.social · 18/09/2025
Excited to finally present the lab's latest work in defining candidate causal genetic variants that drive autoimmune diseases and their effects on primary human T cell expression and function! www.nature.com/articles/s41...
nature.com
Genetic and epigenetic screens in primary human T cells link candidate causal autoimmune variants to T cell networks - Nature Genetics
Massively parallel reporter assay in primary human CD4+ T cells and bulk and single-cell CRISPR-interference screens identify candidate causal variants linked to autoimmune disease risk that modulate ...
23819
Reposted by Kevin Salim
Nature Reviews Endocrinology @natrevendo.nature.com · 13/09/2025
ICYMI: New content online: Antigen-specific Treg cells induce infectious tolerance
nature.com
Antigen-specific Treg cells induce infectious tolerance
Nature Reviews Endocrinology, Published online: 11 September 2025; doi:10.1038/s41574-025-01182-0Antigen-specific Treg cells induce infectious tolerance
031
Reposted by Kevin Salim
DL Wagner Genome Engineering Labs @dlwagnerlabs.bsky.social · 18/09/2025
Lab History pt. 5 (2025) What is the best Knock-in strategy to make CAR-Tregs?? our answer is published in Molecular Therapy 🔗 www.cell.com/molecular-th...
091
Reposted by Kevin Salim
Sarah Crome @sarahcrome.bsky.social · 09/09/2025
This meeting has always been a highlight for the ILC community, and Vancouver 2026 already features an exciting lineup of confirmed speakers. 🔗 ilc6vancouver.com #ILC6 #Immunology #InnateLymphoidCells, #ILC, #ILC2, #ILC3, #NKcells, #ILC1 #Immunosky
ilc6vancouver.com
ILC6
Join leading scientists and emerging researchers in the field of innate lymphoid cells (ILCs) at the 6th international ILC meeting. This event will bring together global experts to discuss groundbreaking advances, foster collaborations, and drive innovation in ILC biology and immunology.
011
Reposted by Kevin Salim
Sarah Crome @sarahcrome.bsky.social · 02/09/2025
Thrilled to share that I’ve officially started my new role as a Senior Scientist in the Terry Fox Laboratory at the BC Cancer Research Centre. I’m excited to join this inspiring community, build new collaborations, and explore bold ideas together.
11396
Reposted by Kevin Salim
Nature Reviews Drug Discovery @natrevdrugdiscov.nature.com · 02/09/2025
Therapeutic strategies aiming to enhance or inhibit regulatory T cell activity are being investigated in diseases including allergy, autoimmune disorders and cancer - find out more in this review by Megan Levings et al. www.nature.com/articles/s41... rdcu.be/eDrL0
nature.com
Harnessing the biology of regulatory T cells to treat disease - Nature Reviews Drug Discovery
Regulatory T cells keep the immune system in check to maintain homeostasis and restrain inflammation. This Review discusses strategies to harness these cells therapeutically for autoimmunity, transpla...
041
Reposted by Kevin Salim
Christos Karampelias @ckarampelias.bsky.social · 24/08/2025
Check out the latest manuscript from the @heikolickert.bsky.social lab on generating a defined stem-cell derived islet product for transplantation. A thorough characterization of the system particularly by our star PhD students Nike and Nicole! #PancSky www.biorxiv.org/content/10.1...
biorxiv.org
Endocrine-enriched stem cell-derived islets improve long-term safety in vivo
Fully differentiated stem cell-derived islets (SC-islets) are proven to normalise blood glucose in type 1 diabetic patients. However, the presence of off-target cell types and the immature SC-islet fu...
0106
Reposted by Kevin Salim
Science Magazine @science.org · 20/08/2025
A hemisphere-spanning study defines synchronicity and climatic influence on dengue in the Americas, polymer-stabilized microparticles enable easy injection of commercial protein therapies, and more this week in #ScienceTranslationalMedicine. scim.ag/4lvOc5i
The cover depicts the presence of human-leukocyte antigen (HLA)-A2-specific chimeric antigen receptor (CAR) regulatory T cells (A2-CAR Tregs) expressing FOXP3 (yellow) and CD3 (red) as well as diabetogenic BDC2.5 T cells expressing vβ4 (cyan) and CD3 in and around transplanted HLA-A2+ NOD. Rag1-/- islets in the eye of an immunodeficient mouse.
0254
Reposted by Kevin Salim
mklevings.bsky.social @mklevings.bsky.social · 20/08/2025
So excited that our paper on CAR Tregs and infectious tolerance made the cover of Science Translational Medicine today! @science.org
262
Reposted by Kevin Salim
Waggoner Lab @labwaggoner.bsky.social · 20/08/2025
HLA-A2–specific chimeric antigen receptor–engineered regulatory T cells tolerize diabetogenic T cells and prevent autoimmune diabetes in mice www.science.org/doi/10.1126/... @mklevings.bsky.social
1101